Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nasdaq Biotechnology Ishares ETF
(NQ:
IBB
)
144.77
-0.83 (-0.57%)
Official Closing Price
Updated: 4:15 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nasdaq Biotechnology Ishares ETF
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
March 13, 2023
The Federal Deposit Insurance Corporation (FDIC) closed Silicon Valley Bank, the banking arm of SVB Financial Group (NASDAQ:
Via
Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per...
Via
Benzinga
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
March 10, 2023
Via
Benzinga
Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births
March 08, 2023
Via
Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
Via
Benzinga
Retail And Regional Banks Will Call The Shots
March 06, 2023
The 23-month moving average or a 2-year business cycle is particularly important this year after a big up then down year-looms large.
Via
Talk Markets
The Economic Modern Family Ready To Howl?
March 05, 2023
As we ended the trading week, there were a few other “worms” that appeared in the market soil. They too seemed to awaken from hibernation as the indices’ prices rose. Are the components of the Economic...
Via
Talk Markets
Bullish Reversals
March 02, 2023
Agricultural commodities have fallen a lot lately. Food supply and shortages remain a concern going into the spring and summer growing seasons.
Via
Talk Markets
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
March 01, 2023
Via
Benzinga
Century Aluminum Pops Up As Bullish
February 27, 2023
Given the recent sell-off in aluminum, copper, and steel, industrial metals remain overall outperformers.
Via
Talk Markets
Stock Market Forecast: Stocks May Drop Further As Rates Rise
February 26, 2023
This week will be full of economic insights, but the big data will be the ISM manufacturing and services indexes. However, I think these two reports are unlikely to do much to reverse the current trend...
Via
Talk Markets
No Landing - Sugar Coated Words For Stagflation?
February 22, 2023
SPX failed the 23-month moving average or 2-year business cycle, which if clears, signals a softer landing. Yet, it held the pivotal 3900 ahead of the Fed, signaling a no landing.
Via
Talk Markets
Is The Whole Country Buying Teslas And Eating At Wingstop?
February 15, 2023
XRT is making lower highs each of the last 3 weeks but also has found a basis of support at 68.00.
Via
Talk Markets
Tuesday Talk: My Sweet CPI
February 14, 2023
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday.
Via
Talk Markets
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
February 13, 2023
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends.
Via
Talk Markets
ARK Invest: The 7 Words That Explain Why Wall Street Can’t Stand Cathie Wood
February 13, 2023
Why does Wall Street hate Cathie Wood and her ARKK ETF? Seven words show how her focus on innovation divides investors.
Via
InvestorPlace
2-Year Business Cycles Matter In Commodities
February 08, 2023
Gold is above the 23-month MA and the 2-year business cycle.
Via
Talk Markets
2-Year Business Cycles Matter In This Market
February 07, 2023
In October, IWM held the 80-month and got us believing that a recession would be averted. Now, the market literally hangs in the balance between a longer-term and a shorter-term business cycle.
Via
Talk Markets
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?
Via
Talk Markets
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...
Via
Benzinga
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
January 30, 2023
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%.
Via
Talk Markets
What Are The Equities Market’s Warning Signs?
January 30, 2023
The 52-week New High / New Low ratio for the Nasdaq Composite has actually begun to deteriorate, a clear Risk-Off indication for the short term.
Via
Talk Markets
Inflation, What Inflation?
January 29, 2023
We typically have a song or two in our heads. After all, watching ticks is musical and has a lot of different beats. And typically, those songs turn into parodies.
Via
Talk Markets
Global Stocks: Breaking Out?
January 28, 2023
The S&P 500 is attempting to clear what has been an insurmountable trendline dating back to January 2022.
Via
Talk Markets
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
Longeveron Shares Surge Following FDA Decision on Biogen Alzheimer's Drug
January 06, 2023
Shares of Longeveron (NASDAQ: LGVN) are trading 5.37% higher amid strength in Alzheimer's-related stocks after the FDA granted accelerated approval to Biogen (NASDAQ: BIIB)'s Leqembi.
Via
Benzinga
SAVA, LLY, IBB: Why These Alzheimer's Related Stocks Are Volatile On Friday
January 06, 2023
Stocks of companies with Alzheimer's candidates, including Cassava Sciences, Inc. (NASDAQ: SAVA) and Eli Lilly And Company (NYSE: LLY), spiked on Friday after the FDA granted accelerated approval to
Via
Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Biopharma stocks were not immune to the broader market downturn seen for much of 2022.
Via
Benzinga
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro
December 19, 2022
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning.
Via
Talk Markets
Tarsus Added to NASDAQ Biotechnology Index
December 16, 2022
From
Tarsus Pharmaceuticals, Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.